116 related articles for article (PubMed ID: 12467073)
21. Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma.
Wang X; Ramaswamy V; Remke M; Mack SC; Dubuc AM; Northcott PA; Taylor MD
Neurosurgery; 2013 Aug; 60 Suppl 1():57-63. PubMed ID: 23839353
[No Abstract] [Full Text] [Related]
22. MRI features of pediatric atypical teratoid rhabdoid tumors and medulloblastomas of the posterior fossa.
Wu HW; Wu CH; Lin SC; Wu CC; Chen HH; Chen YW; Lee YY; Chang FC
Cancer Med; 2023 May; 12(9):10449-10461. PubMed ID: 36916326
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analyses of alpha1 and alpha3 Na+/K+-ATPase subunit expression in medulloblastomas.
Suñol M; Cusi V; Cruz O; Kiss R; Lefranc F
Anticancer Res; 2011 Mar; 31(3):953-8. PubMed ID: 21498719
[TBL] [Abstract][Full Text] [Related]
24. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.
Ellison DW
Acta Neuropathol; 2010 Sep; 120(3):305-16. PubMed ID: 20652577
[TBL] [Abstract][Full Text] [Related]
25. Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.
McManamy CS; Lamont JM; Taylor RE; Cole M; Pearson AD; Clifford SC; Ellison DW;
J Neuropathol Exp Neurol; 2003 Jun; 62(6):627-32. PubMed ID: 12834107
[TBL] [Abstract][Full Text] [Related]
26. [Cerebellar medulloblastoma in a 65-year old patient].
Kroh H; Kostkiewicz B
Neurol Neurochir Pol; 1993; 27(5):757-65. PubMed ID: 8115001
[TBL] [Abstract][Full Text] [Related]
27. Medulloblastoma with cross-striated muscle. A fine structural study.
Misugi K; Liss L
Cancer; 1970 Jun; 25(6):1279-85. PubMed ID: 5422905
[No Abstract] [Full Text] [Related]
28. Medulloblastoma associated with malignant rhabdoid tumor of the kidney: case report.
Watanabe K; Wakai S; Kumakura N; Kurosu A; Nagai M; Tsuchioka T; Fujiwara T
Noshuyo Byori; 1993; 10(1):75-9. PubMed ID: 8220786
[TBL] [Abstract][Full Text] [Related]
29. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
30. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
31. [Expression and clinical significance of cyclooxygenase-2 in medulloblastoma].
Deng QJ; Mao BY; Zhang SF; Tang J; Wang ER
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):641-3. PubMed ID: 15460407
[TBL] [Abstract][Full Text] [Related]
32. Medulloblastoma: present concepts of stratification into risk groups.
Packer RJ; Rood BR; MacDonald TJ
Pediatr Neurosurg; 2003 Jul; 39(2):60-7. PubMed ID: 12845195
[TBL] [Abstract][Full Text] [Related]
33. Biologic risk stratification of medulloblastoma: the real time is now.
Fisher PG; Burger PC; Eberhart CG
J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
[No Abstract] [Full Text] [Related]
34. Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult.
Kawaguchi T; Kumabe T; Watanabe M; Tominaga T
Acta Neurochir (Wien); 2004 Sep; 146(9):1033-8; discussion 1038. PubMed ID: 15340816
[TBL] [Abstract][Full Text] [Related]
35. Successful peripheral blood stem cell harvesting for two pediatric cases of atypical teratoid/rhabdoid tumor with low bodyweight.
Mitani K; Ogata H; Takachi T; Fukui W; Kawaguchi K; Ogura T; Horikoshi Y; Kawasaki T; Watanabe K
Pediatr Blood Cancer; 2024 Mar; 71(3):e30833. PubMed ID: 38177070
[No Abstract] [Full Text] [Related]
36. Diffusion-weighted MRI of haemangioblastomas and other cerebellar tumours.
Quadery FA; Okamoto K
Neuroradiology; 2003 Apr; 45(4):212-9. PubMed ID: 12687303
[TBL] [Abstract][Full Text] [Related]
37. Molecular array analyses of 51 pediatric tumors shows overlap between malignant intracranial ectomesenchymoma and MPNST but not medulloblastoma or atypical teratoid rhabdoid tumor.
Kleinschmidt-DeMasters BK; Lovell MA; Donson AM; Wilkinson CC; Madden JR; Addo-Yobo SO; Lillehei KO; Foreman NK
Acta Neuropathol; 2007 Jun; 113(6):695-703. PubMed ID: 17431644
[TBL] [Abstract][Full Text] [Related]
38. c-myc overexpression causes anaplasia in medulloblastoma.
Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
[TBL] [Abstract][Full Text] [Related]
39. Molecular subgroups of medulloblastoma.
Northcott PA; Dubuc AM; Pfister S; Taylor MD
Expert Rev Neurother; 2012 Jul; 12(7):871-84. PubMed ID: 22853794
[TBL] [Abstract][Full Text] [Related]
40. Medulloblastoma.
Padovani L; André N; Gentet JC; Muracciole X
Eur J Cancer; 2011 Sep; 47 Suppl 3():S338. PubMed ID: 21944006
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
